Global Vaccine Vials Market by Type (Multi Dose, Single Dose), Material (Glass, Polymer), Capacity, Application - Forecast 2024-2030- Product Image

Sale

Global Vaccine Vials Market by Type (Multi Dose, Single Dose), Material (Glass, Polymer), Capacity, Application - Forecast 2024-2030

Report
198 Pages
March 2024
Region: Global
360iResearch™
ID: 5146104

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Vaccine Vials Market size was estimated at USD 629.96 million in 2023, USD 697.72 million in 2024, and is expected to grow at a CAGR of 10.84% to reach USD 1,295.47 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Vaccine Vials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vaccine Vials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Vaccine Vials Market, highlighting leading vendors and their innovative profiles. These include Cardinal Health, Inc., Catalent, Inc., Corning Incorporated, DWK Life Sciences GmbH, Elitech Technology, Inc., ELPRO-BUCHS AG, EVIGENCE SENSORS Inc., Gerresheimer AG, Lisaline Lifescience Technologies Pvt Ltd., Nipro Corporation, Pacific Vial Manufacturing Inc., Schott AG, Stevanato Group, Temptime Corporation by Zebra Technologies Corporation, and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Vaccine Vials Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Multi Dose
- Single Dose
Material
- Glass
- Polymer
Capacity
- 10ml
- 20ml
- 2ml
- 3ml
- 5ml
Application
- Preventive Vaccine
- Therapeutic Vaccine

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Vaccine Vials Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vaccine Vials Market?
What are the technology trends and regulatory frameworks in the Vaccine Vials Market?
What is the market share of the leading vendors in the Vaccine Vials Market?
Which modes and strategic moves are suitable for entering the Vaccine Vials Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Vaccine Vials Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of infectious diseases and demands for number of vaccines
5.1.1.2. Growing initiatives from government and private organizations to advance vaccination
5.1.2. Restraints
5.1.2.1. Lack of healthcare infrastructure
5.1.3. Opportunities
5.1.3.1. Rising preference for high performance packaging solutions
5.1.3.2. Increasing importance of vvm to ensure vaccine safety
5.1.4. Challenges
5.1.4.1. High-cost associated with the supply chain of vaccine vials
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Vaccine Vials Market, by Type

6.1. Introduction
6.2. Multi Dose
6.3. Single Dose

7. Vaccine Vials Market, by Material

7.1. Introduction
7.2. Glass
7.3. Polymer

8. Vaccine Vials Market, by Capacity

8.1. Introduction
8.2. 10ml
8.3. 20ml
8.4. 2ml
8.5. 3ml
8.6. 5ml

9. Vaccine Vials Market, by Application

9.1. Introduction
9.2. Preventive Vaccine
9.3. Therapeutic Vaccine

10. Americas Vaccine Vials Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Vaccine Vials Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Vaccine Vials Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Cardinal Health, Inc.
14.1.2. Catalent, Inc.
14.1.3. Corning Incorporated
14.1.4. DWK Life Sciences GmbH
14.1.5. Elitech Technology, Inc.
14.1.6. ELPRO-BUCHS AG
14.1.7. EVIGENCE SENSORS Inc.
14.1.8. Gerresheimer AG
14.1.9. Lisaline Lifescience Technologies Pvt Ltd.
14.1.10. Nipro Corporation
14.1.11. Pacific Vial Manufacturing Inc.
14.1.12. Schott AG
14.1.13. Stevanato Group
14.1.14. Temptime Corporation by Zebra Technologies Corporation
14.1.15. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. VACCINE VIALS MARKET RESEARCH PROCESS
FIGURE 2. VACCINE VIALS MARKET SIZE, 2023 VS 2030
FIGURE 3. VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VACCINE VIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VACCINE VIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VACCINE VIALS MARKET DYNAMICS
FIGURE 7. VACCINE VIALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. VACCINE VIALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VACCINE VIALS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
FIGURE 10. VACCINE VIALS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VACCINE VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2030 (%)
FIGURE 12. VACCINE VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. VACCINE VIALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. VACCINE VIALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. VACCINE VIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 9. VACCINE VIALS MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VACCINE VIALS MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 12. VACCINE VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VACCINE VIALS MARKET SIZE, BY 20ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. VACCINE VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. VACCINE VIALS MARKET SIZE, BY 3ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VACCINE VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. CANADA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 35. CANADA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 36. CANADA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. MEXICO VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 39. MEXICO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 40. MEXICO VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. CHINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. CHINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 57. CHINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 58. CHINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. INDIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 61. INDIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 62. INDIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. JAPAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 69. JAPAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 70. JAPAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. THAILAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 93. THAILAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 94. THAILAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 106. DENMARK VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 107. DENMARK VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EGYPT VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 110. EGYPT VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 111. EGYPT VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. FINLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 114. FINLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 115. FINLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. FRANCE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 118. FRANCE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 119. FRANCE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. GERMANY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 122. GERMANY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 123. GERMANY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ITALY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 130. ITALY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 131. ITALY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NORWAY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 142. NORWAY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 143. NORWAY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. POLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. POLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 146. POLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 147. POLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. QATAR VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. QATAR VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 150. QATAR VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 151. QATAR VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SPAIN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 166. SPAIN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 167. SPAIN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 178. TURKEY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 179. TURKEY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. VACCINE VIALS MARKET LICENSE & PRICING

Companies Mentioned

Cardinal Health, Inc.
Catalent, Inc.
Corning Incorporated
DWK Life Sciences GmbH
Elitech Technology, Inc.
ELPRO-BUCHS AG
EVIGENCE SENSORS Inc.
Gerresheimer AG
Lisaline Lifescience Technologies Pvt Ltd.
Nipro Corporation
Pacific Vial Manufacturing Inc.
Schott AG
Stevanato Group
Temptime Corporation by Zebra Technologies Corporation
Thermo Fisher Scientific Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	198
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 697.72 Million
Forecasted Market Value ( USD ) by 2030	$ 1295.47 Million
Compound Annual Growth Rate	10.8%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Vaccine Vials Market by Report Type (Multi Dose, Single Dose), Material (Glass, Polymer), Capacity (10ml, 20ml, 2ml, 3ml, 5ml), Application (Preventive Vaccine, Therapeutic Vaccine), and Region 2024-2032

Pharmaceutical Glass Vials And Ampoules - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019-2029

Global Cryogenic Vials Market by Capacity (Capacity 1 ml and Below, Capacity 1ml to 3 ml, Capacity 3 ml to 5 ml), Material (Polyethylene, Polypropylene), Sterility, End-User - Forecast 2024-2030

Pharmaceutical Glass Packaging Market Report by Product (Bottles, Vials, Ampoules, Cartridges and Syringes, and Others), Drug Type (Generic, Branded, Biologic), Application (Oral, Injectable, Nasal, and Others), and Region 2024-2032

Global Autosampler Vials Market